Skip to main content
. 2018 Nov 20;38:89–99. doi: 10.1016/j.ebiom.2018.11.012

Table 1.

Clinico-pathological association of ADAM10 expression in non-luminal breast cancers.

ADAM10 N(%)
p-Value
Low High Total
Grade 1 5 3 8 0.426
2 26 21 47
3 141 81 222
Total 172 105 277
pT 1 52 35 87 0.944
2 103 54 157
3 11 11 22
4 6 3 9
Total 172 103 275
pN 0 85 47 132 0.986
1 42 34 76
2 23 14 37
3 19 9 28
Total 169 104 273
Ki67 Low 111 56 167 0.079a
High 61 48 109
Total 172 104 276
HER2 Negative 98 69 167 0.150
Positive 74 36 110
Total 172 105 277
APP Negative 110 45 155 0.004
Positive 51 45 96
Total 161 90 251
Patients' age Mean 55.3 54.8 54.9 0.662
SD 13.3 12.3 12.9
Range 23–94 30–91
Tumor size Mean 2.96 3.09 3.00 0.742
SD 1.43 1.64 1.51
Range 0.2–8.0 0.5–8.0
a

Indicated features showed significant association with APP in our previous study.